| Miss Hiba Hammad Al Taq, MD | |
|
800 Stanton L Young Blvd # 8400, Oklahoma City, OK 73104-5018 | |
| (405) 271-6173 | |
| (405) 271-5892 |
| Full Name | Miss Hiba Hammad Al Taq |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 800 Stanton L Young Blvd # 8400, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689932352 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 32179 (Oklahoma) | Primary |
| 207R00000X | Internal Medicine | R0724 (Texas) | Secondary |
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
The Dieticians Association of Australia (DAA) has launched the "Healthy Weight Week". The DAA says that 61 per cent of Australian adults and 25 per cent of Australian children are either overweight or obese. At present there are really no drugs that provide long term weight loss. The only resort is surgery.
AbbVie released interim results from an ongoing Phase 2 study of its investigational compound veliparib in combination with chemotherapy, which showed a 35 percent improvement (P-value=0.14) in progression-free survival (PFS) and a 30 percent improvement (P-value=0.21) in overall survival (OS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC).
Use of the weight-loss medication rimonabant produced modest yet sustained weight loss after 2 years, and improved HDL cholesterol and triglyceride levels, according to a study in the February 15 issue of JAMA: The Journal of the American Medical Association.
PLoS Medicine Publications Assistant Michael Morris summarizes several articles published this week in the journal in this PLoS "Speaking of Medicine" blog post.
SCION Instruments, a global supplier of GC, GCMS and Chromatography Data Systems is pleased to announce the release of CompassCDS version 4.0 with new features and capabilities which extend its applicability to a wider range of laboratories.
› Verified 9 days ago
| Entity Name | Questcare Hospitalists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265441620 PECOS PAC ID: 5799785119 Enrollment ID: O20070109000581 |
News Archive
The Dieticians Association of Australia (DAA) has launched the "Healthy Weight Week". The DAA says that 61 per cent of Australian adults and 25 per cent of Australian children are either overweight or obese. At present there are really no drugs that provide long term weight loss. The only resort is surgery.
AbbVie released interim results from an ongoing Phase 2 study of its investigational compound veliparib in combination with chemotherapy, which showed a 35 percent improvement (P-value=0.14) in progression-free survival (PFS) and a 30 percent improvement (P-value=0.21) in overall survival (OS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC).
Use of the weight-loss medication rimonabant produced modest yet sustained weight loss after 2 years, and improved HDL cholesterol and triglyceride levels, according to a study in the February 15 issue of JAMA: The Journal of the American Medical Association.
PLoS Medicine Publications Assistant Michael Morris summarizes several articles published this week in the journal in this PLoS "Speaking of Medicine" blog post.
SCION Instruments, a global supplier of GC, GCMS and Chromatography Data Systems is pleased to announce the release of CompassCDS version 4.0 with new features and capabilities which extend its applicability to a wider range of laboratories.
› Verified 9 days ago
| Entity Name | Questcare Medical Clinics Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821430166 PECOS PAC ID: 6608010541 Enrollment ID: O20130916000718 |
News Archive
The Dieticians Association of Australia (DAA) has launched the "Healthy Weight Week". The DAA says that 61 per cent of Australian adults and 25 per cent of Australian children are either overweight or obese. At present there are really no drugs that provide long term weight loss. The only resort is surgery.
AbbVie released interim results from an ongoing Phase 2 study of its investigational compound veliparib in combination with chemotherapy, which showed a 35 percent improvement (P-value=0.14) in progression-free survival (PFS) and a 30 percent improvement (P-value=0.21) in overall survival (OS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC).
Use of the weight-loss medication rimonabant produced modest yet sustained weight loss after 2 years, and improved HDL cholesterol and triglyceride levels, according to a study in the February 15 issue of JAMA: The Journal of the American Medical Association.
PLoS Medicine Publications Assistant Michael Morris summarizes several articles published this week in the journal in this PLoS "Speaking of Medicine" blog post.
SCION Instruments, a global supplier of GC, GCMS and Chromatography Data Systems is pleased to announce the release of CompassCDS version 4.0 with new features and capabilities which extend its applicability to a wider range of laboratories.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Hiba Hammad Al Taq, MD 1533 Sadie Creek Rd, Edmond, OK 73034-2411 Ph: (716) 342-5929 | Miss Hiba Hammad Al Taq, MD 800 Stanton L Young Blvd # 8400, Oklahoma City, OK 73104-5018 Ph: (405) 271-6173 |
News Archive
The Dieticians Association of Australia (DAA) has launched the "Healthy Weight Week". The DAA says that 61 per cent of Australian adults and 25 per cent of Australian children are either overweight or obese. At present there are really no drugs that provide long term weight loss. The only resort is surgery.
AbbVie released interim results from an ongoing Phase 2 study of its investigational compound veliparib in combination with chemotherapy, which showed a 35 percent improvement (P-value=0.14) in progression-free survival (PFS) and a 30 percent improvement (P-value=0.21) in overall survival (OS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC).
Use of the weight-loss medication rimonabant produced modest yet sustained weight loss after 2 years, and improved HDL cholesterol and triglyceride levels, according to a study in the February 15 issue of JAMA: The Journal of the American Medical Association.
PLoS Medicine Publications Assistant Michael Morris summarizes several articles published this week in the journal in this PLoS "Speaking of Medicine" blog post.
SCION Instruments, a global supplier of GC, GCMS and Chromatography Data Systems is pleased to announce the release of CompassCDS version 4.0 with new features and capabilities which extend its applicability to a wider range of laboratories.
› Verified 9 days ago
Evelyn Lorents, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Patrick Bronson Reeves, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112 Phone: 405-942-5442 Fax: 405-942-6448 | |
Dr. Jake Lee Evans, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Metri Haddaden, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 410-554-2184 | |
Divya Sharma Divyadarshini, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Dr. Philip Barton Miner, Jr., M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104 Phone: 405-271-4644 Fax: 405-271-3296 | |
Gary Lee Worcester, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112 Phone: 405-947-3341 |